Authors:
van Egmond-Frohlich, AWA
Paul, K
Eggert, W
Gaedicke, G
Wahn, U
Bauer, CP
Citation: Awa. Van Egmond-frohlich et al., Familial dysautonomia: A diagnostic dilemma. Chronic lung disease with signs of an autoimmune disease, PEDIAT PULM, 31(6), 2001, pp. 478-481
Authors:
Leucht, S
Uttenreuther-Fischer, MM
Gaedicke, G
Fischer, P
Citation: S. Leucht et al., The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V-H 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy, CLIN IMMUNO, 99(1), 2001, pp. 18-29
Authors:
Niethammer, A
Gaedicke, G
Lode, HN
Wrasidlo, W
Citation: A. Niethammer et al., Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility, BIOCONJ CHE, 12(3), 2001, pp. 414-420
Authors:
Pertl, U
Luster, AD
Varki, NM
Homann, D
Gaedicke, G
Reisfeld, RA
Lode, HN
Citation: U. Pertl et al., IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy, J IMMUNOL, 166(11), 2001, pp. 6944-6951
Authors:
Hoffmann, M
Uttenreuther-Fischer, MM
Lerch, H
Gaedicke, G
Fischer, P
Citation: M. Hoffmann et al., IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia, CLIN EXP IM, 121(1), 2000, pp. 37-46
Authors:
Knoll, K
Wrasidlo, W
Scherberich, JE
Gaedicke, G
Fischer, P
Citation: K. Knoll et al., Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin theta(I), CANCER RES, 60(21), 2000, pp. 6089-6094
Authors:
Vetter, B
Neu-Yilik, G
Kohne, E
Arnold, R
Sinha, P
Gaedicke, G
Ivancevic, V
Kulozik, AE
Citation: B. Vetter et al., Dominant beta-thalassaemia: a highly unstable haemoglobin is caused by a novel 6 bp deletion of the beta-globin gene, BR J HAEM, 108(1), 2000, pp. 176-181
Authors:
Osei, A
Uttenreuther-Fischer, MM
Lerch, H
Gaedicke, G
Fischer, P
Citation: A. Osei et al., Restricted V(H)3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin, ARTH RHEUM, 43(12), 2000, pp. 2722-2732
Authors:
Schmidt, CS
Wrasidlo, W
Scherberich, JE
Gaedicke, G
Fischer, P
Citation: Cs. Schmidt et al., Chemoimmunoconjugates with the monoclonal antibody 138H11 for targeting the cytotoxic prodrug calicheamicin 0 to renal cell carcinomas, TUMOR TARG, 4(4), 1999, pp. 271-277
Authors:
Varnholt, V
Ringe, H
Nietsch, L
Gaedicke, G
Citation: V. Varnholt et al., Hemothorax under thrombolytic therapy with recombinant tissue - Plasminogen activator (rt-PA) in a 16-year-old girl, EUR J PED, 158, 1999, pp. S140-S142
Citation: O. Meyer et al., Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor, TRANSFUSION, 39(5), 1999, pp. 527-530
Authors:
Fischer, P
Jendreyko, N
Hoffmann, M
Lerch, H
Uttenreuther-Fischer, MM
Chen, PP
Gaedicke, G
Citation: P. Fischer et al., Platelet-reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia, BR J HAEM, 105(3), 1999, pp. 626-640
Authors:
Jendreyko, N
Uttenreuther-Fischer, MM
Lerch, H
Gaedicke, G
Fischer, P
Citation: N. Jendreyko et al., Genetic origin of IgG antibodies cloned by phage display and anti-idiotypic panning from three patients with autoimmune thrombocytopenia, EUR J IMMUN, 28(12), 1998, pp. 4236-4247